corporate

healthcare medical

English

ent_TrialEntitlements

ent_LoginStatus

ent_PaidEntitlements

ARRAffinitySameSite

OptanonConsent

ARRAffinity

Domain 'profiles.biocentury.com' uses the commercial generic top-level domain (.com); it also runs on subdomain 'profiles'. The registrable portion 'biocentury' spans 10 characters split between 4 vowels and six consonants. Word splitting yields 2 words: bio, century. Median word length is 5 characters. No strong language cues emerged from the frequency lists.

html/17/5d/175d0a04-1fd4-409f-81ad-cb0e59db1022_fallback.html.gz

Halda Therapeutics LLC - BioCentury Company Profiles - BCIQ

html/17/5d/175d0a04-1fd4-409f-81ad-cb0e59db1022.html.gz

appId=cid-v1:ef1ee613-b79f-4c1f-89a1-2576dfdc022e

inline; filename*=UTF-8''BioCenturyLogo-2021new_BLK.svg

appId=cid-v1:85d0e071-2f8a-4fb5-ba3d-c65ffeaadf25

frame-ancestors https://teams.powerbi.com 'self' https://res-sdf.cdn.office.net https://res.cdn.office.net https://mesh.public.onecdn.static.microsoft https://m365.cloud.microsoft https://outlook.cloud.microsoft https://teams.cloud.microsoft https://teams.microsoft.com https://gov.teams.microsoft.us https://dod.teams.microsoft.us https://teams.microsoftonline.cn https://outlook.office.com https://outlook-sdf.office.com https://outlook.office365.com https://outlook-sdf.office365.com https://www.office.com https://scuprodprv.www.office.com https://www.microsoft365.com https://local.loop.microsoft.com https://dev.loop.microsoft.com https://df.loop.microsoft.com https://loop.microsoft.com

9254893a61cd3bda23adb5b4e730a10a24cebab7b83fdd9ef9df551dd9e3df0b

eff675463cdd7fa83e596bef0da69affed168d370af3f8703993ae42c4d80a10

ab135659fd911eec420c7f1586b70d71d616415247b9a6ddb4a10e234dcd2aa3

c4affb17fd33c3b6aa83dab938f88dbdf024d7de349cb95ed9dc7ac22dfb6703

3a04fc008338e4ee4cd3f9ece3795ab80bf9f9112714a30cc045336ad569f3a7

f44df35e4d43f1f47687bff2d3eb8e840e5bf8cb97a6f9bbc0a093085ad50a95

75d5ca92f05093920d728f0b3e0c1a0bb479ab99c3250f79a8cd0491c706ec91

df4db47a4d4ba97cd41d017b6df0fe33216c47a832c6721111774c08c29db8cf

f4a05984c9c886bea2e95b67ffe9bbb012e65a19d27eab82f816147d866cdb51

9cde3b199842dbc792738320fb6d02666d58af4595677ed223679fe417defd16

119cac30af76b4240562b3419ef0ca20785d76dfc715090f909849a14909b40b

38e9905b8b0bd6a8e5628088536fc85258a054ddd8a066114f116ab30cf3b2b0

c099095b82303f65a7eb1080f01732ba1f645c2ff49b5cc9922ab65d1ae2784f

2428e230f17c6accf3a3ac3b8d2977316af0c11a8289745d4a80ff9e696b1500

b921829c9f38daeeb63ada8cc0034cabaeade74e52acecf4dbccf941a767b136

4fa0d4556c56c758d8f2717eab2e180f279119e19bc5523ab8b140edf0c7ba0b

5d3d139b198cde192d3ee7f07bdb5deb6d7d93c3ba2b3cfd18035c5e8ef19524

e9e9b5861c1bbb1351ae2b7346c1aa586921c308fd49c7fc390494087d46036a

a28d0d18e717e68b1ffb4b96294a44ffa05572b9ed54ee3cdf2baa0cd9a809fb

c05694183603aacf7f8026d3911529acdf0b751aa230e3ee3e51bf7ba63982f0

ee150abe150014f7140b82aade20d8cba00299224d147701d8eda1570ffb359c

bd8c3c1b755033aad6c0270f160e4137a70b4595202df9e1e42e74e8df50f7e0

d8132d45eef1f2500760399505fc221a79a3bbe60ed797bbc24599a650e69927

7420aa3c82e97eb4f4b3be472b0dfa8b7c1c5492c22ce61c21903d62adbd47c7

49d81d84dd3d8009e3bb2a14a8a88cc8e469bb3d63fb77e48916bf9938aea610

d266cebe579de643751bf3548d09af1b3bb2120cbb0aa64b59c8a84871cd8768

22031038e39e75078c3c197b952ade3153e626f53ad9b73a97c1dcb065e76d67

74efe611b319c8594b8dd1880d89d235071c31b254ca4871d9a0a93bf78d35ab

84eef4d88e31309f52937c46fe02c104463293b933f5f72e4ea6b65926f7f216

6d07f3394a888c6a2085c5e2c28b836da7fa79b939a4f97e53fa857c287691f7

df29b507300eba98d94fd856bf7b99799b5ad56f8e662c225dc0929d3c7e3102

e5cb97fa223c0e26669ecc69bd36bba6dc620652eb0eec244c7b6b5ae239f3c1

66ff5c737cdbd89322421c5fd0ade19d173efcec7f2438351006a55f9d3e8a29

Zealand names former Lilly exec Singh as CSO

Science Spotlight: Roche’s intestinal immuno-organoids, cytokine METRNL’s role in tumors, and more

Venture Report: Halda bringing RIPTACs into clinic with crossover round

Canaan’s latest fund smaller than last, reflecting ‘recalibration’ in response to market

Halda: making targeted tumor killing harder to resist via RIPTACs

viewport

robots

Halda Therapeutics LLC - BioCentury Company Profiles for the biopharma industry

description

twitter:card

https://profiles.biocentury.com/companies/halda_therapeutics_llc

twitter:url

twitter:site

twitter:title

twitter:description

https://profiles.biocentury.com/favicon.png

twitter:image

twitter:image:alt

next-head-count

AlK2UR5SkAlj8jjdEc9p3F3xuFYlF6LYjAML3EOqw1g26eCwWPjdmecULvBH5MVPoqKYrOfPhYVL71xAXI1IBQoAAAB8eyJvcmlnaW4iOiJodHRwczovL2RvdWJsZWNsaWNrLm5ldDo0NDMiLCJmZWF0dXJlIjoiV2ViVmlld1hSZXF1ZXN0ZWRXaXRoRGVwcmVjYXRpb24iLCJleHBpcnkiOjE3NTgwNjcxOTksImlzU3ViZG9tYWluIjp0cnVlfQ==

Amm8/NmvvQfhwCib6I7ZsmUxiSCfOxWxHayJwyU1r3gRIItzr7bNQid6O8ZYaE1GSQTa69WwhPC9flq/oYkRBwsAAACCeyJvcmlnaW4iOiJodHRwczovL2dvb2dsZXN5bmRpY2F0aW9uLmNvbTo0NDMiLCJmZWF0dXJlIjoiV2ViVmlld1hSZXF1ZXN0ZWRXaXRoRGVwcmVjYXRpb24iLCJleHBpcnkiOjE3NTgwNjcxOTksImlzU3ViZG9tYWluIjp0cnVlfQ==

A9nrunKdU5m96PSN1XsSGr3qOP0lvPFUB2AiAylCDlN5DTl17uDFkpQuHj1AFtgWLxpLaiBZuhrtb2WOu7ofHwEAAACKeyJvcmlnaW4iOiJodHRwczovL2RvdWJsZWNsaWNrLm5ldDo0NDMiLCJmZWF0dXJlIjoiQUlQcm9tcHRBUElNdWx0aW1vZGFsSW5wdXQiLCJleHBpcnkiOjE3NzQzMTA0MDAsImlzU3ViZG9tYWluIjp0cnVlLCJpc1RoaXJkUGFydHkiOnRydWV9

A93bovR+QVXNx2/38qDbmeYYf1wdte9EO37K9eMq3r+541qo0byhYU899BhPB7Cv9QqD7wIbR1B6OAc9kEfYCA4AAACQeyJvcmlnaW4iOiJodHRwczovL2dvb2dsZXN5bmRpY2F0aW9uLmNvbTo0NDMiLCJmZWF0dXJlIjoiQUlQcm9tcHRBUElNdWx0aW1vZGFsSW5wdXQiLCJleHBpcnkiOjE3NzQzMTA0MDAsImlzU3ViZG9tYWluIjp0cnVlLCJpc1RoaXJkUGFydHkiOnRydWV9

A1S5fojrAunSDrFbD8OfGmFHdRFZymSM/1ss3G+NEttCLfHkXvlcF6LGLH8Mo5PakLO1sCASXU1/gQf6XGuTBgwAAACQeyJvcmlnaW4iOiJodHRwczovL2dvb2dsZXRhZ3NlcnZpY2VzLmNvbTo0NDMiLCJmZWF0dXJlIjoiQUlQcm9tcHRBUElNdWx0aW1vZGFsSW5wdXQiLCJleHBpcnkiOjE3NzQzMTA0MDAsImlzU3ViZG9tYWluIjp0cnVlLCJpc1RoaXJkUGFydHkiOnRydWV9

HSTS header missing - vulnerable to protocol downgrade attacks

CSP header missing - vulnerable to XSS attacks

child-src 'none';object-src 'none';require-trusted-types-for 'script';script-src chrome://resources 'self';trusted-types;worker-src blob: 'self';frame-ancestors 'none';

child-src https:  chrome-untrusted://new-tab-page/ chrome-untrusted://ntp-microsoft-auth/;connect-src chrome://resources chrome://theme 'self';default-src 'self';font-src chrome://resources 'self';img-src chrome://resources chrome://theme chrome://image chrome://favicon2 chrome://app-icon chrome://extension-icon chrome://fileicon blob: data: 'self';object-src 'none';require-trusted-types-for 'script';script-src chrome://resources chrome://webui-test 'self';style-src chrome://resources chrome://theme 'self' 'unsafe-inline';trusted-types parse-html-subset sanitize-inner-html static-types webui-test-script webui-test-html polymer-html-literal polymer-template-event-attribute-policy lit-html-desktop;frame-ancestors 'none';

child-src 'none';object-src 'none';require-trusted-types-for 'script';script-src chrome://resources 'self';trusted-types;frame-ancestors 'none';

base-uri 'none';child-src https:;form-action https://ogs.google.com https://*.corp.google.com;object-src 'none';script-src 'self' 'unsafe-inline' https:;frame-ancestors chrome://new-tab-page/

Domain.com - Network Solutions, LLC

BIOCENTURY.COM

Biocentury


            window.googletag = window.googletag || { cmd: [] };
            googletag.cmd.push(function () {
              googletag.pubads().enableSingleRequest();
              googletag.pubads().disableInitialLoad();
              googletag.enableServices();
            });
          

(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({
            'gtm.start': new Date().getTime(),event:'gtm.js'
          });var f=d.getElementsByTagName(s)[0],j=d.createElement(s),
          dl=l!='dataLayer'?'&l='+l:'';j.async=true;
          j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;
          f.parentNode.insertBefore(j,f); })(
            window, document, 'script',
            'dataLayer', 'GTM-WWLMD4W'
          );

signInButton

SIGN IN

Find partnering and investment opportunities, uncover and track competitive threats, dive into a company's financing and deal history, its pipeline and molecular targets of interest, and much more. Please note, you are viewing a free version of BCIQ, BioCentury's advanced business intelligence database for the biopharma industry. Request a trial to unlock the full value of BCIQ.

REQUEST A FREE TRIAL

AcquiredOrMerged

Cat-H(AcquiredorMerged)

Default (Company Type Blank)

CategoryHDefault (Company Type Blank)

NonBioPharma

Cat-H(NonBioPharma)

PrivateBioPharma

Cat-H(PrivateBioPharma)

PublicBioPharma

Cat-H(PublicBioPharma)

window.AppcuesSettings={enableURLDetection:!0};

Appcues.identify("undefined",{userName:"null",CompanyName:"undefined",PaidEntitlements:"undefined",PaidEntitlementStatus:"undefined",TrialEntitlements:"undefined",TrialEntitlementStatus:"undefined",LoginStatus:"undefined"});

Google

Sentry

✅ Low Risk - https://profiles.biocentury.com/companies/halda_therapeutics_llc

Requests	IP Address	Location	AS Autonomous System
39	20.50.88.234	Amsterdam, North Holland, Netherlands	AS8075MICROSOFT-CORP-MSN-AS-BLOCK
6	142.250.185.194	United States	AS15169GOOGLE
6	142.250.185.65	United States	AS15169GOOGLE
6	142.250.186.66	United States	AS15169GOOGLE
6	146.75.122.132	Frankfurt am Main, Hesse, Germany	AS54113FASTLY
6	54.192.35.98	United States	AS16509AMAZON-02
6	13.107.246.45	United States	AS8075MICROSOFT-CORP-MSN-AS-BLOCK
6	18.66.112.79	United States	Unknown
6	13.107.246.44	United States	AS8075MICROSOFT-CORP-MSN-AS-BLOCK
6	20.50.88.238	Amsterdam, North Holland, Netherlands	AS8075MICROSOFT-CORP-MSN-AS-BLOCK
435	67	-	-

Security Scan Report: profiles.biocentury.com

Summary

AI Security Verdict

Safe Website

Safety Factors

Details

Screenshot

Page Load Overview

Language Analysis

Primary Language

Detection Details

Website Classification

Primary Category

All Detected Categories

Detected Features

Domain & IP Information

Content Similarity HashesFor malware variant detection

TLSH (Trend Micro Locality Sensitive Hash)

ssdeep (Context Triggered Piecewise Hashing)

sdhash (Similarity Digest Hashing)

Image Hashes

Perceptual Hashes

Other Hashes

Scan History